FPH vs GSK · P/E 8.4, rev $27.5M vs P/E 13, $103.31B cap
Five Point Holdings LLC (FPH) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Five Point Holdings LLC (FPH) is a real estate - development company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported FPH revenue for 2026-06-30 was $27.5M. Net income was $8.6M. FPH currently screens at market cap $759.0M and trailing P/E 8.4.
GSK does not have a complete income-statement cache yet.
FPH currently screens at market cap $759.0M and trailing P/E 8.4. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the FPH and GSK stock pages for the full models.
Not investment advice.